PMID- 31013790 OWN - NLM STAT- MEDLINE DCOM- 20190814 LR - 20200225 IS - 1420-3049 (Electronic) IS - 1420-3049 (Linking) VI - 24 IP - 8 DP - 2019 Apr 12 TI - Ameliorative Effect and Mechanism of the Purified Anthraquinone-Glycoside Preparation from Rheum Palmatum L. on Type 2 Diabetes Mellitus. LID - 10.3390/molecules24081454 [doi] LID - 1454 AB - Rheum palmatum L. is a traditional Chinese medicine with various pharmacological properties, including anti-inflammatory, antibacterial, and detoxification effects. In this study, the mechanism of the hypoglycemic effect of purified anthraquinone-Glycoside from Rheum palmatum L. (PAGR) in streptozotocin (STZ) and high-fat diet induced type 2 diabetes mellitus (T2DM) in rats was investigated. The rats were randomly divided into normal (NC), T2DM, metformin (Met), low, middle (Mid), and high (Hig) does of PAGR groups. After six weeks of continuous administration of PAGR, the serum indices and tissue protein expression were determined, and the pathological changes in liver, kidney, and pancreas tissues were observed. The results showed that compared with the type 2 diabetes mellitus group, the fasting blood glucose (FBG), total cholesterol (TC), and triglyceride (TG) levels in the serum of rats in the PAGR treatment groups were significantly decreased, while superoxide dismutase (SOD) and glutathione peroxidase (GSH-PX) levels were noticeably increased. The expression of Fas ligand (FasL), cytochrome C (Cyt-c), and caspase-3 in pancreatic tissue was obviously decreased, and the pathological damage to the liver, kidney, and pancreas was improved. These indicate that PAGR can reduce oxidative stress in rats with diabetes mellitus by improving blood lipid metabolism and enhancing their antioxidant capacity, thereby regulating the mitochondrial apoptotic pathway to inhibitbeta-cell apoptosis and improve beta-cell function. Furthermore, it can regulate Fas/FasL-mediated apoptosis signaling pathway to inhibit beta-cell apoptosis, thereby lowering blood glucose levels and improving T2DM. FAU - Cheng, Fang-Rong AU - Cheng FR AD - College of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, China. chengfr1963888@126.com. FAU - Cui, Hong-Xin AU - Cui HX AD - College of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, China. cuihongxin1974@163.com. AD - Collaborative Innovation Center for Respiratory Disease Diagnosis and Treatment & Chinese Medicine Development of Henan Province, Zhengzhou 450046, China. cuihongxin1974@163.com. FAU - Fang, Ji-Li AU - Fang JL AD - Jiyang College of Zhejiang Agriculture and Forestry University, Zhu'ji 311800, China. fang_qiao418@163.com. FAU - Yuan, Ke AU - Yuan K AD - Jiyang College of Zhejiang Agriculture and Forestry University, Zhu'ji 311800, China. keyuan@zafu.edu.cn. FAU - Guo, Ying AU - Guo Y AD - Zhejiang Chinese Medical University, Zhejiang, Hangzhou 310053, China. littlegy@163.com. LA - eng GR - Grant No: LY16H280007/Zhejiang Provincial Science Foundation of China/ PT - Journal Article DEP - 20190412 PL - Switzerland TA - Molecules JT - Molecules (Basel, Switzerland) JID - 100964009 RN - 0 (Anthraquinones) RN - 0 (Antioxidants) RN - 0 (Glucosides) RN - 0 (Hypoglycemic Agents) RN - EC 1.15.1.1 (Superoxide Dismutase) MH - Animals MH - *Anthraquinones/chemistry/isolation & purification/pharmacology MH - *Antioxidants/chemistry/isolation & purification/pharmacology MH - Diabetes Mellitus, Experimental/*drug therapy/metabolism/pathology MH - Diabetes Mellitus, Type 2 MH - *Glucosides/chemistry/isolation & purification/pharmacology MH - *Hypoglycemic Agents/chemistry/isolation & purification/pharmacology MH - Lipid Metabolism/drug effects MH - Liver/metabolism/pathology MH - Male MH - Oxidative Stress/drug effects MH - Pancreas/metabolism/pathology MH - Rats MH - Rats, Sprague-Dawley MH - Rheum/*chemistry MH - Superoxide Dismutase/metabolism PMC - PMC6515271 OTO - NOTNLM OT - Rheum palmatum L. OT - apoptosis OT - oxidative stress OT - type 2 diabetes mellitus COIS- The authors have no conflicts of interest to declare. All of the authors have approved the final article. EDAT- 2019/04/25 06:00 MHDA- 2019/08/15 06:00 PMCR- 2019/04/12 CRDT- 2019/04/25 06:00 PHST- 2019/02/28 00:00 [received] PHST- 2019/03/27 00:00 [revised] PHST- 2019/04/04 00:00 [accepted] PHST- 2019/04/25 06:00 [entrez] PHST- 2019/04/25 06:00 [pubmed] PHST- 2019/08/15 06:00 [medline] PHST- 2019/04/12 00:00 [pmc-release] AID - molecules24081454 [pii] AID - molecules-24-01454 [pii] AID - 10.3390/molecules24081454 [doi] PST - epublish SO - Molecules. 2019 Apr 12;24(8):1454. doi: 10.3390/molecules24081454.